Latimer, Nicholas; Carroll, Christopher; Wong, Ruth; … - In: PharmacoEconomics 32 (2014) 12, pp. 1171-1183
As part of its single technology appraisal (STA) process, the National Institute for Health and Care Excellence (NICE) invited the manufacturer of rituximab (Roche Products) to submit evidence of the clinical and cost effectiveness of rituximab in combination with corticosteroids for treatment...